Novozymes, Chr. Hansen to Merge, Forming Global Biosolutions Leader
By Lynda Kiernan-Stone, Global AgInvesting Media Novozymes and Chr. Hansen have agreed to a statutory merger that will result in a global biological solutions giant with annual revenue of approximately EUR 3.5 billion (US$3.7 billion). This deal will unite two strategically complementary biosolutions companies into a venture that will unleash the full potential of the […]
